Based on our findings, in silico and in vitro preclinical evaluations verified that ERK1/2 and MEK1 are molecular targets of 22-(4′py)-JA in inducing NSCLC apoptosis. This evidence concerns the gene MAPK3 and non-small cell lung carcinoma.